Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Paclitaxel
- Therapeutic area
- Oncology & immunology
- Drug class
- Antineoplastic medicines
- ATC
- L01CD
- Strength
- 100 mg/16.7 mL
- Dosage form
- Concentrate for solution for infusion
- Pack
- 1's
- Registration no.
- 110575
- Price record verified
- 2026-08-07
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Anzatax (Paclitaxel) is used for
Paclitaxel is an anti-cancer (chemotherapy) medicine from the taxane group. It slows or stops the growth of cancer cells. It is given into a vein as a drip, in a hospital or clinic, by doctors and nurses. A specialist cancer doctor who is experienced in chemotherapy decides when it is used, and your cancer team plans your treatment and checks your blood tests.
- Ovarian cancer, for example after surgery (together with cisplatin) or if platinum medicines have not worked
- Breast cancer, including advanced or spreading breast cancer, and after surgery and other chemotherapy
- Advanced non-small-cell lung cancer, together with cisplatin, when surgery or radiotherapy is not suitable
- Kaposi's sarcoma in people with AIDS, when other treatments have not worked
- WHO's essential medicines list also names it for cancers of the nose and throat area (nasopharynx) and of the neck of the womb (cervix), as well as breast, ovary, lung and Kaposi sarcoma
Get medical help straight away if
- Tell your care team straight away, or get emergency help, for signs of a severe allergic reaction: hives, swelling of the face, lips, mouth, throat, hands or feet, chest tightness, trouble swallowing or breathing, or feeling faint. This can happen during the drip, and staff are watching for it.
- Get urgent help for a fever, severe chills, a sore throat, a cough or mouth ulcers. These can be signs of infection when your white blood cells are low.
- Get urgent help for unusual bruising or bleeding.
- Get urgent help for chest pain, a slow, fast or uneven heartbeat, or fainting.
Side effects, warnings and interactions for Paclitaxel
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
About Anzatax 100 mg/16.7 mL concentrate for solution for infusion
Anzatax 100 mg/16.7 mL concentrate for solution for infusion contains Paclitaxel 100 mg/16.7 mL. It is registered with DRAP by Pfizer Pakistan Limited (registration no. 110575). Its official price is PKR 13,910.00 for a pack of 1's. This price has applied since 1 July 2024. 4 other brands of Paclitaxel 100 mg/16.7 mL (concentrate for solution for infusion) are registered in Pakistan. Compare all brands and prices →
All 4 other brands of Paclitaxel 100 mg/16.7 mL infusion in Pakistan
These 4 brands are alternatives (substitutes) to Anzatax: each contains Paclitaxel 100 mg/16.7 mL infusion. Ask your doctor or pharmacist before you switch brands.
Sorted by price per unit, lowest first. The lowest is Paclitaxel Concentrate (Amgomed) at PKR 11,882 per unit; the highest is Pataxel at PKR 26,848. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Paclitaxel Concentrate | Amgomed | 1's | PKR 11,882.27 | PKR 11,882 / unit |
| Biopac | Merixil Pharma | 1's vial | PKR 16,619.26 | PKR 16,619 / unit |
| Paclitaxel AqVida | Himmel Pharmaceuticals Private Limited | 1's | PKR 17,473.50 | PKR 17,474 / unit |
| Pataxel | Genome Pharmaceuticals (Pvt.) Ltd | 1's | PKR 26,848.45 | PKR 26,848 / unit |
How old is this price? It was fixed on 1 July 2024 and has not changed since — that is 2 years ago. It is still the price the Drug Regulatory Authority of Pakistan has notified, so it remains the official maximum, but it is not a figure from this month. Please check the current position before quoting it in an article, a tender or a purchase order.
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Anzatax, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Pfizer Pakistan Limited, Karachi
- DRAP registration
- 110575
- medinfo_pak@pfizer.com
- Website
- https://www.pfizer.com.pk/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (1's). Current price PKR 13,910.00, effective 1 Jul 2024.
Cite this price history
MedInfoBase. Anzatax 100 mg/16.7 mL, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/anzatax-100-mg-16-7-ml-110575-1s-pfizer-pakistan-limited/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 13,910.00 | 2024-07-01 | 2026-08-07 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 110575Price and registration data on this page were observed on 7 August 2026. Records change over time, so please cite the observation date alongside the access date.